Table 4.

OARSI responder criteria

Number (%) of Responders	0.03 mg (N = 7)	0.1 mg (N = 6)	0.3 mg (N = 6)	1 mg (N = 6)	All (N = 25)	Placebo (N = 8)
Week 4	3 (42.9%)	4 (66.7%)	1 (16.7%)	2 (33.3%)	10 (40%)	1 (12.5%)
Week 8	3 (42.9%)	4 (66.7%)	2 (33.3%)	2 (33.3%)	11 (44%)	0 (0%)
Week 12	1 (14.3%)	4 (66.7%)	2 (33.3%)	1 (16.7%)	8 (32%)	1 (12.5%)
Week 24	1 (14.3%)	5 (83.3%)	2 (33.3%)	1 (20%)	9 (37.5%)	1 (12.5%)